Kura Oncology Inc —— 现金流量表 (NASDAQ:KURA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -69.83 M-104.55 M-110.06 M-124.82 M134.32 M-64.06 M -64.06 M 投资活动产生的现金 -99.94 M-126.83 M32.63 M15.56 M-101.59 M-13.1 M -13.1 M 融资活动产生的现金 469.33 M-3.44 M38.56 M94.78 M154.42 M1.79 M 1.79 M 自由现金流 -72 M-105.7 M-110.69 M-124.99 M133.84 M-70.7 M -70.7 M

新闻

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

UBS因上市数据将Kura Oncology目标价下调至15美元

UBS lowers Kura Oncology stock price target to $15 on launch data

Kura Oncology在Leerink全球医疗保健会议上的战略扩张洞察

Kura Oncology at Leerink Global Healthcare Conference: Strategic Expansion Insights

Kura Oncology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KURA) 2026-03-06

Citizens重申Kura Oncology股票评级,看好强劲上市表现

Citizens reiterates Kura Oncology stock rating on strong launch

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates

Kura OncologyQ1每股收益及营收逊于预期

Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline